The COVID-19 pandemic has undoubtedly marked itself as one of the most significant worldwide occurrences in recent decades, confining almost the entire global population to their homes during its height. As the world gradually moves past the most severe stages of the virus outbreak, many individuals are eager to put it all behind them.
Nevertheless, it is at this crucial juncture that some of the most critical and groundbreaking research can be conducted. Specifically, researchers are focused on unraveling the complexities of the so-called “long-COVID” phenomenon, which encompasses a wide range of persistent cognitive and physiological issues that continue to affect individuals long after the conventional symptoms of the virus have subsided.
“Long COVID” is a term used by the medical community to describe the range of lingering ailments experienced by individuals who have seemingly recovered from the initial virus attack. These symptoms go beyond the usual fever, cough, and respiratory distress of the acute phase. Instead, they result in persistent physical and cognitive impairments that can last for months. These include ongoing shortness of breath, cognitive dysfunction known as “brain fog”, and debilitating fatigue that greatly affects daily functioning.
By delving deeper into this phenomenon, scientists aim to gain a comprehensive understanding of its underlying mechanisms and develop effective interventions to alleviate its long-term impact on individuals’ health and well-being.
Several institutions are currently investigating the long-term effects of the novel Coronavirus on the human body, one of which is IMIC Inc., a clinical trial and medical research facility located in Miami. With a primary focus on gastrointestinal and liver disorders such as Crohn’s Disease and IBD, alongside neurological conditions like Alzheimer’s disease, one might wonder about the connection between these ailments and COVID-19.
Nonetheless, research disseminated through the Miami facility’s website indicates that there is significantly more to explore than initially apparent. According to recent findings published in the journal “Gastroenterology,” patients suffering from inflammatory bowel disease (IBD) who contract COVID-19 do not face an increased risk of severe illness in comparison to those without IBD.
While some may not see the immediate value, it’s crucial to recognize that individuals with inflammatory bowel disease (IBD) have been cautious due to the constant possibility of contracting the novel coronavirus. The fear of worsening their condition and the impact on their quality of life is significant. Shedding light on the way IBD interacts with this virus provides reassurance for this demographic. It emphasizes the importance of ongoing studies, even if not immediately evident to all.
It is thanks to pioneering medical facilities like IMIC that the world can gain a deeper understanding of the long-lasting repercussions of this virus variant and the interrelated concerns surrounding pre-existing health conditions.
Since 2009, IMIC has operated as a research center in Miami, with their new site in Palmetto Bay fully functional since January 2015, providing service to the South Dade area ever since. The clinic stands as a clinical research center, fully furnished with the necessary equipment and experienced staff needed to enroll patients in clinical trials.
As the fight against the lingering effects of the pandemic virus continues, knowledge about the intersectionality of such pre-existing conditions with this novel virus is crucial for affected patients and healthcare providers alike. The work done by institutions like IMIC Research plays a vital role in unraveling the mysteries of long-COVID and empowering the global community with the necessary information to tackle the pandemic head-on.
As COVID-19 continues to leave a lasting imprint on our world, medical research facilities like IMIC contribute to the plethora of knowledge surrounding this pandemic. With their commitment to understanding the myriad ways in which coronavirus variants interact with various pre-existing conditions, the world inches closer to a more comprehensive grasp of this formidable virus, allowing for improved treatment and care for those affected in the
